Inter-professional variability in the assignment and recording of acute toxicity grade using the RTOG system during prostate radiotherapy.

BACKGROUND AND PURPOSE To compare the routine acute toxicity documentation practices of therapists and oncologists using the RTOG lower GI and GU scales. METHODS AND MATERIALS Ninety consecutive prostate radiotherapy patients were identified. The weekly urinary and rectal acute toxicity grades routinely documented by therapists and oncologists were collected retrospectively from radiotherapy charts. These data were paired together, and compared between the professional groups. RESULTS Only RTOG acute toxicity grades between 0 and 2 were recorded by either group. The overall rate of documentation was high (97% therapists/86% oncologists), but the rate of quantitative documentation was low from the oncologists (46%) who used a free-form text field for recording purposes. There was no significant difference in the incidence of maximum grade of acute toxicity reported by either professional group (p>0.1). There was good RTOG score concordance between the observer groups (kappa=0.756), with pair-wise absolute agreement in 76%. Pair-wise discrepancies between the observers were commonly attributable to differences in the time/date of assessment. CONCLUSIONS Despite some methodological limitations, this study found that therapist-assessed RTOG acute toxicity grades demonstrated a good level of agreement with the grades assigned by their oncologist colleagues.

[1]  Axel Ekkernkamp,et al.  Comparison of handheld computer-assisted and conventional paper chart documentation of medical records. A randomized, controlled trial. , 2004, Journal of Bone and Joint Surgery. American volume.

[2]  Lawrence B Marks,et al.  Normal tissue effects: reporting and analysis. , 2003, Seminars in radiation oncology.

[3]  V. Moravan,et al.  Preliminary Reliability and Validity Testing of a New Skin Toxicity Assessment Tool (STAT) in Breast Cancer Patients Undergoing Radiotherapy , 2004, American journal of clinical oncology.

[4]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[5]  T. Rosewall,et al.  Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. , 2007, International journal of radiation oncology, biology, physics.

[6]  Acs Task Force on Professionalism Code of professional conduct. , 2003 .

[7]  S. Simon,et al.  Quality and correlates of medical record documentation in the ambulatory care setting , 2002, BMC health services research.

[8]  D. Opila The Impact of Feedback to Medical Housestaff on Chart Documentation and Quality of Care in the Outpatient Setting , 1997, Journal of General Internal Medicine.

[9]  D. Cella,et al.  Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions. , 1998, Statistics in medicine.

[10]  M. Moran,et al.  Measuring medical residents' chart-documentation practices. , 1988, Journal of medical education.

[11]  S. Bentzen,et al.  The need for adverse effects reporting standards in oncology clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Weber,et al.  Documentation of severe pain, opioid doses, and opioid-related side effects in outpatients with cancer: a retrospective study. , 1999, Journal of pain and symptom management.

[13]  F. Spijkervet,et al.  Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy , 1999, Cancer.

[14]  M. Parliament,et al.  Is cancer treatment toxicity accurately reported? , 1985, International journal of radiation oncology, biology, physics.

[15]  P. White,et al.  Guidelines and legal requirements which inform role expansion in radiography , 2002 .

[16]  Avraham Eisbruch,et al.  Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[17]  P. Hogg,et al.  Advanced radiographic practice—the legal aspects , 2003 .

[18]  David A. Scalzitti,et al.  Introduction to Research in the Health Sciences , 2009 .

[19]  B. Zee,et al.  Assessing the reliability of two toxicity scales: implications for interpreting toxicity data. , 1993, Journal of the National Cancer Institute.

[20]  M. Villalobos,et al.  Breast Cancer Acute Radiotherapy Morbidity Evaluated by Different Scoring Systems , 2002, Breast Cancer Research and Treatment.

[21]  F. Mellor,et al.  Longitudinal changes in extended roles in radiography , 2002 .

[22]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[23]  J. Ioannidis,et al.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.

[24]  David A Jaffray,et al.  On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. , 2004, International journal of radiation oncology, biology, physics.